Clinical analysis of temporary pacemaker implantation in 6 children with fulminant myocarditis

Min Zhang1, Xiaofang Cai2, Yong Zhang3

  • 1The Children's Heart Center, 100 Hongkong Road, Jiangan District, Wuhan, Hubei, China.

Insights

Temporary pacemakers are safe and effective for children with fulminant myocarditis and severe heart block. This intervention can improve heart function in pediatric patients experiencing bradycardia.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Electrophysiology

Background:

  • Fulminant myocarditis in children can lead to severe bradycardia and atrioventricular block.
  • Literature on temporary pacemaker use in this pediatric population is limited.
  • This study reviews the experience at a single center.

Purpose of the Study:

  • To summarize the use and outcomes of temporary pacemakers in children with fulminant myocarditis.
  • To evaluate the safety and efficacy of temporary pacing in this critical condition.

Main Methods:

  • Retrospective analysis of clinical data from Wuhan Children's Hospital (January 2017 - May 2022).
  • Inclusion criteria: children diagnosed with fulminant myocarditis requiring temporary pacemaker insertion.
  • Data collected included patient demographics, pacing parameters, and outcomes.

Main Results:

  • Six children (4 boys, 2 girls; median age 50 months) with third-degree atrioventricular block (III°AVB) were included.
  • Temporary pacemakers were placed an average of 2.75 hours post-admission.
  • Sinus rhythm recovery occurred in 5 patients within 61 hours; one required a permanent pacemaker.

Conclusions:

  • Temporary pacemakers demonstrate high safety in pediatric fulminant myocarditis.
  • Pacing effectively improves heart function in children with severe bradycardia or III°AVB due to myocarditis.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...